๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Urotensin-II: a novel systemic hypertensive factor in the cat

โœ Scribed by DavidJ. Behm; ChristopherP.A. Doe; DouglasG. Johns; Kristeen Maniscalco; GeraldP. Stankus; Alexandra Wibberley; RobertN. Willette; StephenA. Douglas

Book ID
105876347
Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
196 KB
Volume
369
Category
Article
ISSN
0028-1298

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Recombinant human antiโ€“transforming grow
Recombinant human antiโ€“transforming growth factor ฮฒ1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
โœ Christopher P. Denton; Peter A. Merkel; Daniel E. Furst; Dinesh Khanna; Paul Eme ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 157 KB ๐Ÿ‘ 1 views

## Abstract ## Objective To evaluate CATโ€192, a recombinant human antibody that neutralizes transforming growth factor ฮฒ1 (TGFฮฒ1), in the treatment of earlyโ€stage diffuse cutaneous systemic sclerosis (dcSSc). ## Methods Patients with SSc duration of <18 months were randomly assigned to the place